StockWatch
·

VIVIMED LABS LTD. Q4 FY25 Results

VIVIMEDLABQ4 FY25 Results
Filing
MetricValue ( Cr)vs Q3 FY25
Revenue25.6129.8%
Total Income29.8318.4%
Expenditure34.8418.1%
PBT-5.0116.1%
Net Profit-5.1314.2%
OPM-7.81%28.18pp
NPM-17.18%0.84pp
EPS-3.09329.2%
View full financials

Informational and educational content only. Not investment advice.